Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 419

1.

Allergy to local anesthetics: Reality or myth?

Malinovsky JM, Chiriac AM, Tacquard C, Mertes PM, Demoly P.

Presse Med. 2016 Jul 1. pii: S0755-4982(16)30129-4. doi: 10.1016/j.lpm.2016.05.011. [Epub ahead of print]

PMID:
27378513
2.

Delayed hypersensitivity reaction to loperamide: An intriguing case report with positive challenge test.

Nahas O, Alary V, Chiriac AM, Philibert C, Demoly P, Hillaire-Buys D.

Allergol Int. 2016 Jun 27. pii: S1323-8930(16)30082-X. doi: 10.1016/j.alit.2016.05.011. [Epub ahead of print] No abstract available.

3.

Allergic Rhinitis Control Test questionnaire-driven stepwise strategy to improve allergic rhinitis control: a prospective study.

Wang Y, Chen H, Zhu R, Liu G, Huang N, Li W, Yang L, Zhang S, Qi S, Daurès JP, Chiriac AM, Demoly P.

Allergy. 2016 Jun 22. doi: 10.1111/all.12963. [Epub ahead of print]

PMID:
27332957
4.

Drug hypersensitivity workup for suspected pristinamycin drug hypersensitivity.

Schrijvers R, Lagara K, Breynaert C, Demoly P, Chiriac AM.

J Allergy Clin Immunol Pract. 2016 Jun 8. pii: S2213-2198(16)30120-9. doi: 10.1016/j.jaip.2016.04.010. [Epub ahead of print] No abstract available.

PMID:
27289495
5.

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.

Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Zuberbier T; MASK study group*.

J Allergy Clin Immunol. 2016 Apr 23. pii: S0091-6749(16)30148-8. doi: 10.1016/j.jaci.2016.03.025. [Epub ahead of print]

6.

Surveying the new allergic and hypersensitivity conditions chapter of the International classification of diseases (ICD)-11.

Tanno LK, Calderon MA, Papadopoulos NG, Sanchez-Borges M, Moon HB, Sisul JC, Jares EJ, Sublett JL, Casale T, Demoly P; Joint Allergy Academies.

Allergy. 2016 Jun 2. doi: 10.1111/all.12945. [Epub ahead of print]

PMID:
27253871
7.

[Allergy to neuromuscular blocking agents].

Chiriac AM, Demoly P.

Presse Med. 2016 May 24. pii: S0755-4982(16)30049-5. doi: 10.1016/j.lpm.2016.02.023. [Epub ahead of print] French.

PMID:
27234905
8.

Reply.

Demoly P, Kleine-Tebbe J.

J Allergy Clin Immunol. 2016 May 24. pii: S0091-6749(16)30198-1. doi: 10.1016/j.jaci.2016.03.034. [Epub ahead of print] No abstract available.

PMID:
27233151
9.

Comparison of allergenic extracts from different origins: the value of the FDA's bioequivalent allergy unit (BAU).

Passalacqua G, Sastre J, Pfaar O, Wahn U, Demoly P.

Expert Rev Clin Immunol. 2016 Jul;12(7):733-9. doi: 10.1080/1744666X.2016.1187561. Epub 2016 May 30.

PMID:
27215895
11.

Anaphylaxis case report to trimethylphloroglucinol (Spasfon®).

Nahas O, Nkashama-Tshiaba L, Demoly P, Chiriac AM.

Allergol Int. 2016 May 14. pii: S1323-8930(16)30041-7. doi: 10.1016/j.alit.2016.04.004. [Epub ahead of print] No abstract available.

12.

Phenotypical characterization of children with hypersensitivity reactions to NSAIDs.

Cousin M, Chiriac A, Molinari N, Demoly P, Caimmi D.

Pediatr Allergy Immunol. 2016 May 12. doi: 10.1111/pai.12596. [Epub ahead of print]

PMID:
27171669
13.

Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper.

Brockow K, Aberer W, Atanaskovic-Markovic M, Bavbek S, Bircher A, Bilo B, Blanca M, Bonadonna P, Burbach G, Calogiuri G, Caruso C, Celik G, Cernadas J, Chiriac A, Demoly P, Oude Elberink JN, Fernandez J, Gomes E, Garvey LH, Gooi J, Gotua M, Grosber M, Kauppi P, Kvedariene V, Laguna JJ, Makoswska J, Mosbech H, Nakonechna A, Papadopolous NG, Ring J, Romano A, Rockmann H, Sargur R, Sedlackova L, Sigurdardottir S, Schnyder B, Storaas T, Torres M, Zidarn M, Terreehorst I.

Allergy. 2016 May 4. doi: 10.1111/all.12929. [Epub ahead of print]

PMID:
27145347
14.

New Allergic and Hypersensitivity Conditions Section in the International Classification of Diseases-11.

Tanno LK, Calderon MA, Demoly P; Joint Allergy Academies.

Allergy Asthma Immunol Res. 2016 Jul;8(4):383-8. doi: 10.4168/aair.2016.8.4.383.

15.

Updating Allergy and/or Hypersensitivity Diagnostic Procedures in the WHO ICD-11 Revision.

Tanno LK, Calderon MA, Li J, Casale T, Demoly P; Joint Allergy Academies.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):650-7. doi: 10.1016/j.jaip.2016.01.015. Epub 2016 Apr 20. Review.

PMID:
27107691
16.

Methodological aspects of a meta-analysis of grass pollen allergen sublingual immunotherapy tablets.

Cox LS, Didier A, Demoly P, Wahn U, Pradalier A, Frew AJ, Devillier P.

J Allergy Clin Immunol. 2016 Jul;138(1):314-315.e4. doi: 10.1016/j.jaci.2016.01.039. Epub 2016 Apr 12. No abstract available.

PMID:
27084407
17.

Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey.

Demoly P, Broué-Chabbert A, Wessel F, Chartier A.

Allergy Asthma Clin Immunol. 2016 Apr 11;12:13. doi: 10.1186/s13223-016-0119-z. eCollection 2016.

18.

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

Dhami S, Nurmatov U, Roberts G, Pfaar O, Muraro A, Ansotegui IJ, Calderon M, Cingi C, Demoly P, Durham S, van Wijk RG, Halken S, Hamelmann E, Hellings P, Jacobsen L, Knol E, Linnemann DL, Lin S, Maggina V, Oude-Elberink H, Pajno G, Panwankar R, Pastorello E, Pitsios C, Rotiroti G, Timmermans F, Tsilochristou O, Varga EM, Wilkinson J, Williams A, Worm M, Zhang L, Sheikh A.

Clin Transl Allergy. 2016 Mar 22;6:12. doi: 10.1186/s13601-016-0099-6. eCollection 2016.

19.

In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper.

Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, Vultaggio A, Brockow K, Caubet JC, Makowska J, Nakonechna A, Romano A, Montañez MI, Laguna JJ, Zanoni G, Gueant JL, Oude Elberink H, Fernandez J, Viel S, Demoly P, Torres MJ; In vitro tests for Drug Allergy Task Force of EAACI Drug Interest Group.

Allergy. 2016 Aug;71(8):1103-34. doi: 10.1111/all.12886. Epub 2016 May 25.

PMID:
26991315
20.

Paving the way of systems biology and precision medicine in allergic diseases: The MeDALL success story.

Bousquet J, Anto JM, Akdis M, Auffray C, Keil T, Momas I, Postma D, Valenta R, Wickman M, Cambon-Thomsen A, Haahtela T, Lambrecht BN, Lodrup-Carlsen K, Koppelman GH, Sunyer J, Zuberbier T, Annesi-Maesano I, Arno A, Bindslev-Jensen C, De Carlo G, Forastiere F, Heinrich J, Kowalski ML, Maier D, Melén E, Palkonen S, Smit HA, Standl M, Wright J, Arsanoj A, Benet M, Balardini N, Garcia-Aymerich J, Gehring U, Guerra S, Hohman C, Kull I, Lupinek C, Pinart M, Skrindo I, Westman M, Smagghe D, Akdis C, Albang R, Anastasova V, Anderson N, Bachert C, Ballereau S, Ballester F, Basagana X, Bedbrook A, Bergstrom A, von Berg A, Brunekreef B, Burte E, Carlsen KH, Chatzi L, Coquet JM, Curin M, Demoly P, Eller E, Fantini MP, Gerhard B, Hammad H, von Hertzen L, Hovland V, Jacquemin B, Just J, Keller T, Kerkhof M, Kiss R, Kogevinas M, Koletzko S, Lau S, Lehmann I, Lemonnier N, McEachan R, Mäkelä M, Mestres J, Minina E, Mowinckel P, Nadif R, Nawijn M, Oddie S, Pellet J, Pin I, Porta D, Rancière F, Rial-Sebbag A, Saes Y, Schuijs MJ, Siroux V, Tischer CG, Torrent M, Varraso R, De Vocht J, Wenger K, Wieser S, Xu C.

Allergy. 2016 Mar 10. doi: 10.1111/all.12880. [Epub ahead of print] Review.

PMID:
26970340
Items per page

Supplemental Content

Loading ...
Write to the Help Desk